Peng Du

1.1k total citations
50 papers, 832 citations indexed

About

Peng Du is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Peng Du has authored 50 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cancer Research and 11 papers in Surgery. Recurrent topics in Peng Du's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (9 papers) and Circular RNAs in diseases (8 papers). Peng Du is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (9 papers) and Circular RNAs in diseases (8 papers). Peng Du collaborates with scholars based in China, Czechia and United States. Peng Du's co-authors include Yiwei Liao, Haiting Zhao, Renjun Peng, Gang Peng, Qing Liu, Xiaopan Xu, Jian Yuan, Hongbing Lu, Yang Liu and Haitao Fan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Small and Science Advances.

In The Last Decade

Peng Du

46 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Du China 17 463 364 134 131 130 50 832
Sophie Domhan Germany 11 400 0.9× 134 0.4× 96 0.7× 209 1.6× 133 1.0× 15 864
Lucheng Zhu China 16 277 0.6× 194 0.5× 87 0.6× 261 2.0× 229 1.8× 54 713
Guannan Tang China 14 407 0.9× 366 1.0× 54 0.4× 78 0.6× 170 1.3× 23 726
Tim N. Beck United States 14 352 0.8× 151 0.4× 52 0.4× 114 0.9× 298 2.3× 28 756
Marie‐Lisa Eich United States 15 361 0.8× 162 0.4× 59 0.4× 200 1.5× 149 1.1× 40 717
Lei Zhu China 17 261 0.6× 124 0.3× 189 1.4× 226 1.7× 189 1.5× 65 785
Qiang Zuo China 13 417 0.9× 200 0.5× 57 0.4× 133 1.0× 315 2.4× 39 805
Jiandong Wang China 16 635 1.4× 687 1.9× 96 0.7× 81 0.6× 121 0.9× 37 989
Xinhong He China 13 224 0.5× 165 0.5× 70 0.5× 83 0.6× 125 1.0× 30 484

Countries citing papers authored by Peng Du

Since Specialization
Citations

This map shows the geographic impact of Peng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Du more than expected).

Fields of papers citing papers by Peng Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Du. The network helps show where Peng Du may publish in the future.

Co-authorship network of co-authors of Peng Du

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Du. A scholar is included among the top collaborators of Peng Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Du. Peng Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhao, Haiting, Meng Li, Peng Du, et al.. (2024). IDH1 mutation produces R-2-hydroxyglutarate (R-2HG) and induces mir-182-5p expression to regulate cell cycle and tumor formation in glioma. Biological Research. 57(1). 30–30. 1 indexed citations
3.
Jiang, Yi‐Zhou, Chen Shao, Wenting Peng, et al.. (2022). Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer. Cell Reports. 38(9). 110460–110460. 37 indexed citations
4.
Liu, Chen, Teli Liu, Xiaojiang Duan, et al.. (2022). Preclinical evaluation and first in human study of Al18F radiolabeled ODAP-urea-based PSMA targeting ligand for PET imaging of prostate cancer. Frontiers in Oncology. 12. 1030187–1030187. 6 indexed citations
5.
Zhao, Haiting, Peng Du, Renjun Peng, et al.. (2021). Long Noncoding RNA OR7E156P/miR-143/HIF1A Axis Modulates the Malignant Behaviors of Glioma Cell and Tumor Growth in Mice. Frontiers in Oncology. 11. 690213–690213. 8 indexed citations
6.
Yang, Lihui, Peng Du, Jian Li, et al.. (2021). LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN. Neoplasma. 68(4). 788–797. 27 indexed citations
7.
Xu, Xiaopan, Huanjun Wang, Yan Guo, et al.. (2021). Study Progress of Noninvasive Imaging and Radiomics for Decoding the Phenotypes and Recurrence Risk of Bladder Cancer. Frontiers in Oncology. 11. 704039–704039. 16 indexed citations
8.
Yuan, Shuo, Ning Fan, Yong Hai, et al.. (2021). What is the impact of scoliotic correction on postoperative shoulder imbalance in severe and rigid scoliosis. BMC Musculoskeletal Disorders. 22(1). 868–868. 2 indexed citations
9.
Du, Peng, et al.. (2021). PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis. International Journal of Medical Sciences. 18(15). 3588–3598. 13 indexed citations
10.
Tan, Zhao-Li, Yong Shao, Peng Du, et al.. (2020). PRSS contributes to cetuximab resistance in colorectal cancer. Science Advances. 6(1). eaax5576–eaax5576. 32 indexed citations
11.
Yang, Fan, et al.. (2020). M2 bone marrow-derived macrophage-derived exosomes shuffle microRNA-21 to accelerate immune escape of glioma by modulating PEG3. Cancer Cell International. 20(1). 93–93. 58 indexed citations
12.
Wang, Lifang, et al.. (2020). Cyclin-dependent kinase 6 (CDK6) is a candidate diagnostic biomarker for early non-small cell lung cancer. Translational Cancer Research. 9(1). 95–103. 9 indexed citations
13.
Liu, Yang, Haojie Zheng, Xiaopan Xu, et al.. (2020). The invasion depth measurement of bladder cancer using T2-weighted magnetic resonance imaging. BioMedical Engineering OnLine. 19(1). 92–92. 8 indexed citations
14.
15.
Zhang, Chang, Shuang Wang, Xiaoyan Yu, et al.. (2019). A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan. Journal of Immunology Research. 2019. 1–12. 7 indexed citations
16.
Du, Peng, Haiting Zhao, Renjun Peng, et al.. (2017). LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway. Bioscience Reports. 37(5). 98 indexed citations
17.
Tian, Qiu‐Hong, et al.. (2017). Effect of antitumor treatments on triple-negative breast cancer patients. Medicine. 96(45). e8389–e8389. 7 indexed citations
18.
Zhao, Haiting, Renjun Peng, Qing Liu, et al.. (2016). The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP. Archives of Biochemistry and Biophysics. 610. 1–7. 73 indexed citations
19.
Du, Peng, et al.. (2014). Evaluation of renal perfusion changes in acute phase with CT perfusion imaging after percutaneous nano knife ablation in pig kidney. Zhonghua fangshexian yixue zazhi. 48(11). 952–955. 1 indexed citations
20.
He, Yangyang, Yu Yan, Chang Zhang, et al.. (2014). Establishment of a novel cell-based assay for screening small molecule antagonists of human interleukin-6 receptor. Acta Pharmacologica Sinica. 35(11). 1453–1462. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophie Domhan Breakdown of academic impact, for papers by Lucheng Zhu Breakdown of academic impact, for papers by Guannan Tang Breakdown of academic impact, for papers by Tim N. Beck Breakdown of academic impact, for papers by Marie‐Lisa Eich Breakdown of academic impact, for papers by Lei Zhu Breakdown of academic impact, for papers by Qiang Zuo Breakdown of academic impact, for papers by Jiandong Wang Breakdown of academic impact, for papers by Xinhong He
Rankless by CCL
2026